Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: A systematic review

Integrative Cancer Therapies

Volumn 4, Issue 4, 2005, Pages 274-286

  Verhoef, Marja J ^a   Balneaves, Lynda G ^b   Boon, Heather S ^c   Vroegindewey, Annette ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Complementary and alternative medicine; Decision making; Systematic review

Indexed keywords

AGE DISTRIBUTION; ALTERNATIVE MEDICINE; BIBLIOGRAPHIC DATABASE; CANCER RESEARCH; CANCER THERAPY; CLINICAL TRIAL; DECISION MAKING; FEMALE; GENDER; HUMAN; MALE; META ANALYSIS; MULTICENTER STUDY; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; SYSTEMATIC REVIEW; THEORETICAL MODEL; UNITED STATES;

ADULT; COMPLEMENTARY THERAPIES; DEMOGRAPHY; HUMANS; NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 28144461506     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534735405282361     Document Type: Review

References (68)

1. What is complementary and alternative medicine (CAM)? [National Center for Complementary and Alternative Medicine Web site.] Available at: http://nccam.nih.gov/health/ whatiscam/#6-. Accessed August 23, 2004.
2. Risberg T, Lund E, Kaasa S, Wilsgaard T. Cancer patients' use of non-proven therapy: a 5-year follow-up study. J Clin Oncol. 1995;16:6-12.
3. Ernst E, Cassileth BR. The prevalence of complementary/ alternative medicine in cancer. Cancer. 1998;83:777-782.
4. Boon H, Brown JB, Gavin A, Kennard A, Stewart M. Breast cancer survivors' perceptions of complementary/alternative medicine (CAM): making the decision to use or not to use. Qual Health Res. 1999;9:639-653.
5. Boon H, Stewart M, Kennard MA, et al. Use of complementary/ alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000;18:2515-2521.
6. Balneaves LG, Kristjanson LJ, Tataryn D. Beyond convention: describing complementary therapy use by women living with breast cancer. Patient Educ Couns. 1999;38:143-153.
7. Montbriand MJ. Decision tree model describing alternate health care choices made by oncology patients. Cancer Nurs. 1995;18:104-117.
8. Truant T, Bottorff JL. Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns. 1999;38:131-142.
9. Sparber A, Wooton J. Surveys of complementary and alternative medicine: part II. Use of alternative and complementary cancer therapies. J Altern Complement Med. 2001;7:281-287.
10. DiGianni L, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002;20:34-38.
11. Giordano J, Boatwright D, Stapleton S, Huff L. Blending the boundaries: steps toward an integration of complementary and alternative medicine into mainstream practice. J Altern Complement Med. 2002;8:897-906.
12. Gozum S, Tezel A, Koc M. Complementary alternative treatments used by patients with cancer in Eastern Turkey. Cancer Nurs. 2003;26:230-236.
13. Moschen R, Kemmler G, Schweigkofler H, et al. Use of alternative/ complementary therapy in breast cancer patients-a psychological perspective. Support Care Cancer. 2001;9:267-274.
14. Lengacher CA, Bennet MP, Kip KE, et al. Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum. 2002;29:1445-1452.
15. Mackenzie E, Taylor L, Bloom BS, Hufford DJ, Johnson JC. Ethnic minority use of complementary and alternative medicine (CAM): a national survey of CAM utilizers. Altern Ther Health Med. 2003;9:50-56.
16. Maskarinec G, Shumay DM, Kakai H, Gotay CG. Ethnic differences in complementary and alternative medicine use among cancer patients. J Altern Complement Med. 2000;6:531-538.
17. Ceylan S, Hamzaoglu O, Komurcu S, Beyan C, Yalcin A. Survey of the use of complementary and alternative medicine among Turkish cancer patients. Complement Ther Med. 2002;10:94-99.
18. Gotay CC, Hara W, Issell BF, Maskarinec G. Use of complementary and alternative medicine in Hawaii cancer patients. Hawaii Med J. 1999;58:94-98.
19. Nam RK, Fleshner N, Rakovitch E, et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol. 1999;161:1521-1524.
20. Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003;62:849-853.
21. Lee MM, Lin SS, Wrensch RM, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42-47.
22. Jordan ML, Delunas LR. Quality of life and patterns of non-traditional therapy use by patients with cancer. Oncol Nurs Forum. 2001;28:1107-1113.
23. Adler SR. Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q. 1999;13:214-222.
24. Maxwell JA. Qualitative Research Design: An Interactive Approach. Thousand Oaks, CA: Sage; 1996:14-24
25. Adler SR. Relationships among older patients, CAM practitioners and physicians: the advantages of qualitative inquiry. Altern Ther Health Med. 2003;9:104-110.
26. O'Connor AM, Legare F, Stacey D. Risk communication in practice: the contribution of decision aids. BMJ. 2003;327:736-740.
27. O'Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2005:1.
28. Whelan T, Sawka C, Levine M, et al. Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst. 2003;98:581-587.
29. Beyerstein BL. Alternative medicine and common errors of reasoning. Acad Med. 2001;76:230-237.
30. Downer SM, Cody MM, McCluskey, et al. Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ. 1994;309:86-89.
31. Risberg T, Lund E, Wist E, et al. The use of non-proven therapy among patients treated in Norwegian oncological departments: a cross-sectional national multi-centre study. Eur J Cancer. 1995;31A:1785-1789.
32. Risberg T, Lund E, Wist E. Use of non-proven therapies: differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol. 1995;34:893-898.
33. Munstedt K, Kirsch W, Milch W, Sachsse S, Vahrson H. Unconventional cancer therapy-survey of patients with gynaecological malignancy. Arch Gynaecol Obstet. 1996;258:81-88.
34. Begbie SD, Kerestes ZL, Bell DR. Patterns of alternative medicine use by cancer patients. Med J Aust. 1996;165:545-548.
35. Liu JM, Chu HC, Chin YH, et al. Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol. 1997;27:37-41.
36. Risberg T, Kaasa S, Wist E, Melsom H. Why are cancer patients using non-proven complementary therapies? A cross-sectional multi-centre study in Norway. Eur J Cancer. 1997;33:575-580.
37. Crocetti E, Crotti E, Feltrin A, Ponton P, Geddes M, Buiatti E. The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer. 1998;34:324-328.
38. Oneschuk D, Fennell L, Hanson J, Bruera E. The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care. 1998;14:21-26.
39. Burstein HJ, Gelber S, Guaddagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340:1733-1739.
40. Lippert MC, McClain R, Boyd JC, Theodorescu D. Alternative medicine use in patients with localized prostate carcinoma treated with curative intent. Cancer. 1999;86:2642-2648.
41. Verhoef MJ, Hagen N, Pelletier G, Forsyth P. Alternative therapy use in neurologic disease: use in brain tumor patients. Neurology. 1999;52:617-622.
42. Warrick PD, Irish JC, Morningstar M, Gilbert R, Brown D, Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 1999;125:573-579.
43. Wyatt GK, Friedman LL, Given CW, Given BA, Beckrow KC. Complementary therapy use among older cancer patients. Cancer Pract. 1999;7:136-144.
44. Kao GD, Devine P. Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer 2000;88:615-619.
45. Malik LA, Nasseeruddin A, Khan A, Khan W. Use of unconventional methods of therapy by cancer patients in Pakistan. Eur J Epidemiol. 2000;16:155-160.
46. Morris KT, Johnson N, Homer L, Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg. 2000;179:407-411.
47. Rees RW, Feigel I, Vickers A, Zollmann C, McGurk R, Smith C. Prevalence of complementary therapy use by women with breast cancer: a population based survey. Eur J Cancer. 2000;36:1359-1364.
48. Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18:2505-2514.
49. Sparber A, Bauer L, Curt G, et al. Use of complementary medicine by adults participating in cancer clinical trials. Oncol Nurs Forum. 2000;27:623-630.
50. Alferi SM, Antoni MH, Ironson G, Kilbourn KM, Carver CS. Factors predicting the use of complementary therapies in a multi-ethnic sample of early stage breast cancer patients. J Am Med Womens Assoc. 2001;56:120-126.
51. Paltiel O, Avitzour M, Peretz T, et al. Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol. 2001;19:2439-2448.
52. Samur M, Bozcuk HS, Kara A, Savas B. Factors associated with utilization of non proven cancer therapies in Turkey. Support Care Cancer. 2001;9:452-458.
53. Jones HA, Metz JM, Devine P, Hahn SM, Whittington R. Rates of unconventional medical therapy use in patients with prostate cancer: standard history versus directed questions. Urology. 2002;59:272-276.
54. Patterson RE, Neuhouser ML, Hedderson MM, et al. Types of alternative medicine used by patients with breast, colon or prostate cancer: predictors, motives and costs. J Altern Complement Med. 2002;8:477-485.
55. Salmenpera L. The use of complementary therapies among breast and prostate cancer patients in Finland. Eur J Cancer Care (Engl). 2002;11:44-50.
56. Shen J, Andersen R, Albert PS, et al. Use of complementary/ alternative therapies by women with advanced breast cancer. BMC Complement Altern Med. 2002;2:8.
57. Shumay DM, Maskarinec CG, Gotay C, Heiby EM, Kakai H. Determinants of the degree of complementary and alternative medicine use among patients with cancer. J Altern Complement Med. 2002;8:661-671.
58. Tough SC, Johnston DW, Verhoef MJ, Arthur K, Bryant H. Complementary and alternative medicine use among colorectal cancer patients in Alberta, Canada. Altern Ther Health Med. 2002;8:54-64.
59. Wilkinson S, Gomella LG, Smith JA, et al. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002;68:2505-2509.
60. Chrystal K, Simon A, Forgeson G, Isaacs R. The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J. 2003;116:1168. Available at: http://www.nzma.org.n7./journal/116-1168/296/.
61. Eng J, Ramsum D, Verhoef M, Guns E, Davison J, Gallagher R. A population based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer. Integr Cancer Ther. 2003;2:221-216.
62. Hall JD, Bissonette EA, Boyd JC, Theodorescu D. Motivations and influences on the use of complementary medicine in patients with localized prostate cancer treated with curative intent: results of a pilot study. Br J Urol. 2003;91:603-607.
63. Harris P, Finlay IG, Cook A, Thomas KH, Hood K. Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complement Ther Med. 2003;11:249-253.
64. Ponholzer A, Struhal G, Madersbacher S. Frequent use of complementary medicine by prostate cancer patients. Eur Urol. 2003;43:604-608.
65. Yoshimura K, Ichioka K, Terada N, Terai A, Arai Y. Use of complementary and alternative medicine by patients with localized prostate carcinoma: a study at a single institute in Japan. Int J Clin Oncol. 2003;8:26-30.
66. Henderson JW, Donatelle R. Complementary and alternative medicine use by women after completion of allopathic treatment for breast cancer. Altern Ther Health Med. 2004;10:52-57.
67. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynaecologic or breast malignancies. J Clin Oncol. 2004;22:671-677.
68. Cui Y, Shu X, Gao Y, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263-270.